No Data
No Data
Are Investors Undervaluing Zynex, Inc. (NASDAQ:ZYXI) By 36%?
Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces
ENGLEWOOD, Colo., July 11, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain
All You Need to Know About Zynex (ZYXI) Rating Upgrade to Buy
RBC Capital Reiterates Outperform on Zynex, Maintains $15 Price Target
RBC Capital analyst Shagun Singh reiterates Zynex (NASDAQ:ZYXI) with a Outperform and maintains $15 price target.
Zynex to Participate in Fireside Chat With RBC Capital Markets on Thursday, June 13, 2024
Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for...
Why Zynex, Inc. (NASDAQ:ZYXI) Looks Like A Quality Company